Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QUARTET USA
NCT03640312Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- Aug 2019
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irbesartan + amlodipine + indapamide + bisoprolol in hypertension (HTN), sponsored by Washington University School of Medicine. Started Aug 2019; status: completed.
02
Drugs
irbesartan + amlodipine + indapamide + bisoprolol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03640312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03640312.